Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Stille

193.50 SEK

+2.11 %

Less than 1K followers

STIL

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+2.11 %
+9.63 %
-15.87 %
-10.83 %
-6.97 %
-9.15 %
+58.61 %
+112.64 %
+86.68 %

Stille develops, manufactures and markets medical devices for specialist surgeons. Priority areas are surgical instruments and special tables for cardiovascular surgery, gynecology and urology. The company's products are used by users on a global level. In addition to its core business, it also offers instrument care training. Stille was originally founded in 1841 and has its headquarters in Eskilstuna.

Read more
Market cap
1.74B SEK
Turnover
313.27K SEK
Revenue
569.95M
EBIT %
12.36 %
P/E
29.86
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12.2
2026

Annual report '25

24.4
2026

Interim report Q1'26

23.7
2026

Interim report Q2'26

All
Press releases
ShowingAll content types
Press release10/27/2025, 1:31 PM

Redeye: Stille (Q3 update) - Prolonged headwind but valuation remains undemanding

Stille
Regulatory press release10/23/2025, 6:00 AM

Stille AB (publ) today presents the report for the third quarter 2025.

Stille
Regulatory press release10/15/2025, 6:00 AM

Stille AB announces new Executive Management and group structure

Stille

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release9/18/2025, 2:00 PM

Johan Lundholm to leave his Position as “Business Unit Manager – Surgical Tables” of Stille

Stille
Regulatory press release8/1/2025, 12:00 PM

Stille completes the acquisition of Surgical Holdings

Stille
Press release7/21/2025, 6:21 AM

Redeye: Stille Q2 2025 - Temporary weakness, expected rebound in H2

Stille
Regulatory press release7/17/2025, 6:00 AM

Stille AB: Interim Report Q2 2025

Stille
Regulatory press release7/2/2025, 4:15 PM

Stille has entered into an agreement to acquire Surgical Holdings

Stille
Regulatory press release5/9/2025, 6:00 AM

Stille AB appoints Ulrik Berthelsen as Chief Executive Officer

Stille
Regulatory press release5/7/2025, 2:15 PM

Report from Stille’s Annual General Meeting 2025

Stille
Regulatory press release4/29/2025, 11:00 AM

Niklas Carlén to Leave is Position as CFO of Stille

Stille
Press release4/25/2025, 7:43 AM

Redeye: Stille Q1 2025 - Softer than anticipated but just a temporary bump on the road

Stille
Regulatory press release4/24/2025, 6:00 AM

Stille AB: Interim Report Q1 2025

Stille
Regulatory press release4/9/2025, 7:00 AM

Notice of Annual General Meeting of Stille AB

Stille
Regulatory press release4/4/2025, 6:00 AM

Stille AB: Annual Report 2024

Stille
Press release2/14/2025, 8:57 AM

Redeye: Stille Q4 2024 - Bags another strong quarter

Stille
Regulatory press release2/13/2025, 7:00 AM

Stille AB: Year-end Report 2024

Stille
Regulatory press release2/4/2025, 8:00 AM

The Nomination Committee’s Proposal for a New Board at Stille AB

Stille
Regulatory press release12/11/2024, 10:00 PM

Torbjörn Sköld resigns as Stille’s CEO in June 2025

Stille
Regulatory press release11/25/2024, 7:00 AM

Stille launches imagiQ3™ at RSNA 2024

Stille
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.